theheart.org : CME programs

Interventional/Surgery

Stent Trials: Dealing With the Deluge of Data

Mar 12, 2010 11:10 EST

Join Drs. Garratt and Waksman as they discuss the recent information overload from drug-eluting stent trials and to what extent these data impact their clinical practice.

Thrombosis

Secondary Prevention of Venous Thromboembolism: Current Controversies and Emerging Therapies

Mar 10, 2010 16:26 EST

Venous thromboembolism (VTE), a common but preventable disease, is associated with significant mortality and morbidity. Patients who have had a primary VTE event are at an increased risk for recurrence, but the risk is not uniform and secondary prophylaxis is associated with bleeding risk. The challenge then is to identify patients at high risk for recurrence who would benefit the most from extended secondary prophylaxis. Dr. Alexander G. G. Turpie presents a clinical update on the issues surrounding this rapidly evolving area and the agents in clinical development which have the potential to replace existing therapies.

Interventional/Surgery

PCI in the ACS Patient With Multivessel Disease

Mar 10, 2010 10:31 EST

Despite data suggesting that only the culprit lesion should be treated in ACS patients, it's often hard to ignore significant blockages seen on angiography. Dr. Feres presents a case to Drs. Bhatt and King who discuss strategies to quantify risk and manage ACS patients with multivessel disease.

Arrhythmia/EP

Ablation of Atrial Fibrillation and Ventricular Tachycardia: Present and Future

1 COMMENT - Feb 26, 2010 10:18 EST

Join Drs. Prystowsky, Jaïs, and Stevenson for a discussion on the appropriate use of ablation in the management of patients with atrial fibrillation or ventricular tachycardia.

Arrhythmia/EP

Issues in Arrhythmia Management: Troubleshooting ICD Devices

Feb 25, 2010 16:03 EST

Join Drs. Prystowsky and Akula for a case-based discussion on troubleshooting implantable cardioverter defibrillators in patients that experience inappropriate shocks.

Primary and Secondary Prevention of CVD and Stroke in Women

Racial/Ethnic Disparities: CVD in African American Women

Feb 24, 2010 10:29 EST

Drs. Hayes and Ofili discuss disparities in the care of African American women with CVD, followed by Dr. Mitchell's presentation on heart failure.

Interventional/Surgery

Cath Lab 2012

Feb 23, 2010 14:00 EST

Drs Moses, Singh and DeGregorio present a series of challenging case studies of patients with complex cardiovascular lesions and discuss how new and evolving technologies will impact the management of these patients.

Interventional/Surgery

Transcatheter Aortic Valves: Highlights From Leipzig 2009

Feb 19, 2010 13:49 EST

Recorded at the Dallas-Leipzig meeting 2009. Watch presentations by Drs. Dewey, Kappetein, Schuler, and Walther bookended by commentary from course directors, Drs. Mack and Mohr.

Arrhythmia/EP

Focus On: Anticoagulation in AF and ACS

Feb 16, 2010 13:42 EST

Join Drs. Halperin, Wallentin, and Oldgren as they discuss the results of the RE-LY post-hoc analysis, the RE-DEEM trial in ACS results, and the role of anticoagulants and antiplatelet therapy in clinical practice

Acute Coronary Syndromes

Focus on Antiplatelet Therapy at AHA 2009

Feb 12, 2010 14:07 EST

CHAMPION, PLATO, and OPTIMUS were among the trials featured at AHA. Read Dr. Prasad's review and watch presentations by Drs. Angiolillo, Gurbel, Harrington, and Storey.

Acute Coronary Syndromes

The Key to Their Hearts: The Indispensable Role of the Primary Care Clinician in the Management of Patients Post-MI

Feb 12, 2010 10:16 EST

Drs Toth and McPherson discuss the importance of collaboration between PCPs and cardiologists in managing patients with ACS to decrease adverse outcomes and mortality. They review the ACC/AHA guidelines for appropriate length of therapy, risk factor reduction, and medication use before and after interventions.

Prevention

Precursors of Cardiovascular Disease and Emerging Strategies With Statins

Feb 9, 2010 09:57 EST

Dyslipidemia is only one signal of cardiovascular disease (CVD) risk. Inflammation is a frequent precursor of cardiac-related events. Drs. Willerson, Ballantyne, and Ridker critically examine the mechanisms of atherosclerosis, elevated C-reactive protein and other risk factors, and statin therapy to preemptively address or ameliorate CVD.

Acute Coronary Syndromes

Best Practices in STEMI Management: The Crossroads of Bleeding and Outcomes

Feb 3, 2010 10:49 EST

Dr. Gabriel Steg introduces a discussion between Drs. Anthony Gershlick and Martial Hamon on achieving a balance between favorable outcomes and reducing bleeding in STEMI patients.

Thrombosis

Best practices in VTE prophylaxis: apply the guidelines in patients with cancer

Jan 29, 2010 14:06 EST

Dr. Khorana summarizes the risk factors for VTE in patients with cancer and describes the current strategies for prophylaxis.

Hypertension

Perspectives on the 4th World Symposium on Pulmonary Hypertension

Jan 29, 2010 10:28 EST

Join Dr. Frantz as he reviews and provides his expert perspectives on the Dana Point classification and treatment guidelines for PAH.

Arrhythmia/EP

Cardiac Resynchronization Therapy: Do Recent Data Warrant a Change in the Guidelines?

Jan 28, 2010 16:24 EST

Join Drs. Prystowsky and Wilber as they discuss the results of pivotal cardiac resynchronization therapy trials in heart failure and their potential impact on the current treatment paradigm and guidelines.

Arrhythmia/EP

Risk Stratification in HF and CRT: How Do We Reconcile LV Ejection Fraction, QRS Duration, and NYHA Class?

Jan 27, 2010 10:59 EST

Join Drs. Marchlinski, Bax, and Estes for a discussion on recent CRT-D trials, the impact of therapy in early-stage HF patients, and how LVEF, QRS duration, and NYHA class may guide treatment.

Acute Coronary Syndromes

Antiplatelets in PCI: Doses and Choices

2 COMMENTS - Jan 21, 2010 13:36 EST

Recent data on aspirin and clopidogrel dosing in PCI have left many confused. Dr. Ohman navigates through the data with Drs. Gurbel and Storey.

Arrhythmia/EP

Contemporary Management of Arrhythmia: Practice-Based Approaches

Jan 20, 2010 13:58 EST

Advances have improved the ability to diagnose, prevent, and treat cardiac arrhythmias and associated conditions. Learn about ongoing improvements in arrhythmia management from a stellar Mayo Clinic faculty.

Clinical cardiology

Optimizing Outcomes in Ischemic Heart Disease Management: Issues and Answers

Jan 19, 2010 09:39 EST

Explore key issues in ischemic heart disease, including accurate diagnosis, risk stratification, and data involving new antianginal therapies.

Acute Coronary Syndromes

Antiplatelet Therapy for Atherothrombotic Disease: Taking the Next Steps

1 COMMENT - Jan 4, 2010 14:37 EST

Examine current perspectives in antiplatelet therapy on emerging agents vs current therapy, and review data from recently completed clinical trials.

Prevention

Managing Dysglycemia in Cardiovascular Disease: Preventing Future Events

Dec 29, 2009 15:48 EST

Little success has been realized in achieving target levels for glycemic control, lipids, and blood pressure, as a result the number of patients with diabetes in the U.S. with these risk factors has increased. Drs. Davidson, Blumenthal, and Svec discuss appropriate treatments to guide the physician in the prevention of CVD.

Thrombosis

Preventing Symptomatic, Recurrent Deep Vein Thrombosis or Pulmonary Embolism: The Need for Long-Term Thromboprophylaxis

Dec 23, 2009 11:49 EST

Join Dr. Graham Turpie as he discusses exciting new data on novel oral anticoagulation therapy released at ASH.

Arrhythmia/EP

Advances in Cardiac Resynchronization Therapy and Left Ventricular Reverse Remodeling in Heart Failure

Dec 22, 2009 10:19 EST

Join Drs. Fonarow, Gold, and Klein as they discuss recent clinical trial data in cardiac resynchronization therapy and left ventricular reverse remodeling in early-stage heart failure patients.

Interventional/Surgery

DES Comparisons: Insights From Late-term Follow-up

2 COMMENTS - Dec 21, 2009 11:25 EST

COMPARE, ENDEAVOR IV, SIRTAX-LATE, SPIRIT IV -- given the abundance of data comparing the various DES are there any patterns emerging? Dr. King leads a panel discussion with Drs. Cohen and Williams.